Cargando…

Lactate-dehydrogenase associated with mortality in hospitalized patients with COVID-19 in Mexico

Detalles Bibliográficos
Autores principales:	Zhu, Feiyan, Li, Xiaofei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Fundación Clínica Médica Sur, A.C. Published by Elsevier España, S.L.U. 2021
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8045453/ https://www.ncbi.nlm.nih.gov/pubmed/33864949 http://dx.doi.org/10.1016/j.aohep.2021.100348

Ejemplares similares

Reply to: Lactate-dehydrogenase associated with mortality in hospitalized patients with COVID-19 in Mexico
por: Vidal-Cevallos, Paulina, et al.
Publicado: (2021)

Lactate dehydrogenase, COVID-19 and mortality
por: Bartziokas, Konstantinos, et al.
Publicado: (2021)

Lactate dehydrogenase, COVID-19 and mortality
por: Bartziokas, Konstantinos, et al.
Publicado: (2021)

Lactate-dehydrogenase associated with mortality in hospitalized patients with COVID-19 in Mexico: a multi-centre retrospective cohort study
por: Vidal-Cevallos, Paulina, et al.
Publicado: (2021)

Stability of lactate dehydrogenase in plasma at different temperatures: post-analytical storage
por: López, Marta Gómez, et al.
Publicado: (2020)

Prognostic value of lactate dehydrogenase for in-hospital mortality in severe and critically ill patients with COVID-19
por: Dong, Xingtong, et al.
Publicado: (2020)

Lactate dehydrogenase elevations is associated with severity of COVID-19: a meta-analysis
por: Chen, Xiao-Yun, et al.
Publicado: (2020)

Hospital mortality in mechanically ventilated COVID-19 patients in Mexico
por: Ñamendys-Silva, Silvio A., et al.
Publicado: (2020)

Lactation and COVID-19 Infection
por: Kaur, Hardeep, et al.
Publicado: (2022)

Comment on “Association of obesity with illness severity in hospitalized patients with COVID-19: A retrospective cohort study”
por: Yang, Qunying, et al.
Publicado: (2021)

Evaluation of the anti-tumor effects of lactate dehydrogenase inhibitor galloflavin in endometrial cancer cells
por: Han, Xiaoyun, et al.
Publicado: (2015)

Reply to: Comments on “Association of liver abnormalities with in-hospital mortality in patients with COVID-19”
por: Ding, Ze-yang, et al.
Publicado: (2021)

High Mortality Among Health Personnel With COVID-19 in Mexico
por: Domínguez-Varela, Irving Armando
Publicado: (2020)

Aminotransferases disorders associated with venous thromboembolic events in patients infected with COVID-19
por: Zhu, Xiangyu, et al.
Publicado: (2021)

Letter regarding “Association of liver abnormalities with in-hospital mortality in patients with COVID-19”
por: Luo, Meng-Si, et al.
Publicado: (2021)

Serum lactate dehydrogenase isoenzyme 1 as a prognostic predictor for metastatic testicular germ cell tumours
por: von Eyben, F E, et al.
Publicado: (2000)

In-Hospital Mortality Risk of Older Patients With COVID-19 Infection
por: Kawada, Tomoyuki
Publicado: (2022)

Association of Vitamin D Status and COVID-19-Related Hospitalization and Mortality
por: Speeckaert, Marijn M., et al.
Publicado: (2022)

Serum lactate dehydrogenase isoenzyme 1 as a prognostic predictor for metastatic testicular germ cell tumours – reply
por: Shamash, J
Publicado: (2000)

Lactose Dehydrogenase in Patients with Severe COVID-19: A Meta-Analysis of Retrospective Study
por: Huang, Xiaoyi, et al.
Publicado: (2020)

rs11046147 mutation in the promoter region of lactate dehydrogenase‐B as a potential predictor of prognosis in triple‐negative breast cancer
por: Liu, Jia, et al.
Publicado: (2020)

Serum lactate dehydrogenase level may predict acute respiratory distress syndrome of patients with fever infected by SARS-CoV-2
por: Zhou, Yang, et al.
Publicado: (2020)

Outbreak of Candida auris infection in a COVID-19 hospital in Mexico
por: Villanueva-Lozano, Hiram, et al.
Publicado: (2021)

Reply to “In-Hospital Mortality Risk of Older Patients With COVID-19 Infection”
por: Covino, Marcello, et al.
Publicado: (2022)

Association of admission serum levels of neurofilament light chain and in-hospital mortality in geriatric patients with COVID-19
por: Marchegiani, Francesca, et al.
Publicado: (2022)

In-hospital use of ACEI/ARB is associated with lower risk of mortality and critic illness in COVID-19 patients with hypertension
por: Yuan, Yuan, et al.
Publicado: (2020)

Risk factors for hospitalization, intensive care, and mortality among patients with asthma and COVID-19
por: Wang, Liqin, et al.
Publicado: (2020)

Temporal changes in co-morbidities and mortality in patients hospitalized for COVID-19 in Italy
por: Angeli, Fabio, et al.
Publicado: (2020)

Low-dose hydroxychloroquine therapy and lower mortality in hospitalized patients with COVID-19: association does not mean causality
por: De Schryver, Nicolas, et al.
Publicado: (2021)

The role of heparin in reducing in-hospital complications and three-month mortality rates in hospitalized COVID-19 patients
por: Calabretta, F., et al.
Publicado: (2022)

Association of liver steatosis and fibrosis with clinical outcomes in patients with SARS-CoV-2 infection (COVID-19)
por: Li, Xiaofei
Publicado: (2021)

Mexico and the COVID-19 Response
por: Ibarra-Nava, Ismael, et al.
Publicado: (2020)

Serum lactate dehydrogenase level is associated with in-hospital mortality in critically Ill patients with acute kidney injury
por: Zhang, Dan, et al.
Publicado: (2021)

Association of Lactate Dehydrogenase with In-Hospital Mortality in Patients with Acute Aortic Dissection: A Retrospective Observational Study
por: He, Huaping, et al.
Publicado: (2020)

Scores based on neutrophil percentage and lactate dehydrogenase with or without oxygen saturation predict hospital mortality risk in severe COVID-19 patients
por: Fan, Xiude, et al.
Publicado: (2021)

Reply to ‘Low‐dose hydroxychloroquine therapy and lower mortality in hospitalized patients with COVID‐19: association does not mean causality’
por: Dauby, N., et al.
Publicado: (2021)

The Lactate and the Lactate Dehydrogenase in Inflammatory Diseases and Major Risk Factors in COVID-19 Patients
por: Gupta, G. S.
Publicado: (2022)

Comment on “Increased in-hospital mortality from COVID-19 in patients with schizophrenia”. Considering the prevalence and protective factors of COVID-19 in patients with schizophrenia
por: Ekinci, O., et al.
Publicado: (2022)

Lactate dehydrogenase predicting mortality in patients with aneurysmal subarachnoid hemorrhage
por: Zan, Xin, et al.
Publicado: (2022)

Response to Letters to the Editor RE: Association of Vitamin D Status and COVID-19-Related Hospitalization and Mortality
por: Seal, Karen H., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ce2kd8p4trenm0al8sp5lklhc2